Avant Diagnostics, Inc Net Change in Cash
Avant Diagnostics, Inc reported Net Change in Cash of $31.35 thousand for the 3-month period ending 2018-12-31, per its 10-Q filed 2019-03-13.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2019-03-13
- Avant Diagnostics, Inc cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2018-12-31 was $31.35K, a 36.81% decline year-over-year.
- Avant Diagnostics, Inc cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2017-12-31 was $49.62K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month |
|---|---|
| 2018-12-31 | $31.35K 10-Q · filed 2019-03-13 |
| 2017-12-31 | $49.62K 10-Q · filed 2019-03-13 |